Is CHWY a Buy? What to Consider in 2026
Short answer
The bull case for Chewy (CHWY) rests on Autoship makes the revenue sticky: Autoship, Chewy's auto-replenishment subscription, drives roughly 83% of net sales, which is rare predictability for a retailer. FY2025 net sales is About $12.60 billion, up 6.2% (roughly 8.3% on a 52-week basis). If you believe that thesis holds, the real questions become position sizing and overlap, not timing. The main risk to that view: Chewy operates in a structurally low-margin retail business, so even with mix improvements its net margins sit in the low single digits and small cost or pricing shifts matter a lot. Whether CHWY is a buy comes down to whether you believe the thesis. This is informational, not a recommendation, and Walnut is not an investment adviser.
Chewy is the largest pure-play online retailer of pet products in the United States, selling pet food, treats, supplies, prescription medications, and other essentials, plus a growing set of pet-health services. The core of the model is Autoship, an auto-replenishment subscription that schedules recurring deliveries of food and supplies; Autoship accounts for roughly 83% of net sales, which gives Chewy unusually predictable, repeat-purchase revenue for a retailer. The company makes most of its money on product sales at retail-style gross margins, but it is steadily mixing in higher-margin revenue from Chewy Pharmacy, sponsored ads through its Chewy Ads retail-media network, and veterinary care. In fiscal 2025 (the year ended February 1, 2026) Chewy reported net sales of about $12.60 billion, up 6.2% (roughly 8.3% on a comparable 52-week basis), with around 21.3 million active customers and net sales per active customer near $600. Chewy was founded in 2011, sold to PetSmart in 2017, and went public in 2019; the private-equity firm BC Partners (through its PetSmart ownership) was the longtime majority holder and has been steadily selling down its stake through secondary offerings, often paired with Chewy share buybacks. Profitability has improved markedly: fiscal 2025 net income was about $222.8 million, adjusted EBITDA reached roughly $719 million (up about 26%), and free cash flow hit a record near $562 million. Management has leaned into two growth bets in particular: a fast-scaling retail-media advertising business that executives credit as a main driver of gross-margin gains, and a push into veterinary care, including the 2026 agreement to acquire Modern Animal, which lifted Chewy Vet Care's clinic footprint from 18 toward 47 sites with a target of roughly 60. In the first quarter of fiscal 2026 (ended May 3, 2026), net sales grew 7.7% to about $3.36 billion with net income of $94.8 million.
What's the case for buying CHWY?
1. Autoship makes the revenue sticky.
Autoship, Chewy's auto-replenishment subscription, drives roughly 83% of net sales, which is rare predictability for a retailer. Pet food and medications are non-discretionary, repeat purchases, so the base tends to hold up even in weaker consumer environments. With around 21.3 million active customers and net sales per active customer near $600, the model compounds as existing customers buy more categories. The strategic question is less about losing customers and more about how much more Chewy can sell each one.
2. Higher-margin businesses are the profit lever.
Chewy is layering more profitable revenue on top of low-margin product sales. The Chewy Ads retail-media network, launched in 2023, has roughly doubled its advertisers and is the business management credits as a primary driver of gross-margin expansion. Gross margin reached about 29.8% in fiscal 2025 and 30.1% in the first quarter of fiscal 2026. Chewy Pharmacy adds another structurally higher-margin stream, helping adjusted EBITDA margin climb toward the mid-single digits with guidance around 6.6% to 6.8% for fiscal 2026.
3. Vet care extends the ecosystem.
Chewy is building a physical pet-health footprint to capture more of the roughly $40 billion Americans spend on pet healthcare. Its 2026 agreement to acquire Modern Animal lifts Chewy Vet Care from 18 clinics toward 47, with a target of around 60 locations, and is expected to add more than $125 million of annualized run-rate revenue. Management expects clinic customers to spend meaningfully more across Chewy overall. The clinics are an investment that is expected to break even around 2026 and contribute to profit later, so the payoff is multi-year.
4. Cash generation and buybacks.
Chewy is now firmly cash-generative, posting record free cash flow of about $562 million in fiscal 2025. It returns capital through share repurchases rather than a dividend, deploying roughly $200 million on buybacks in the first quarter of fiscal 2026 alone, often alongside secondary offerings as BC Partners sells down its stake. Net income of about $222.8 million in fiscal 2025 and $94.8 million in the latest quarter show the business is profitable on a GAAP basis. The buyback program also helps offset dilution from share-based compensation, which remains a meaningful expense.
What are the risks to CHWY?
Chewy operates in a structurally low-margin retail business, so even with mix improvements its net margins sit in the low single digits and small cost or pricing shifts matter a lot. Growth has slowed as the US pet market matures, with net sales up only about 6% in fiscal 2025 and active-customer growth modest after a long stretch of flat-to-declining counts following the pandemic pet boom. Competition is intense and well-capitalized: Amazon, Walmart, big-box pet chains like PetSmart and Petco, and local veterinarians all compete for the same wallet. The vet-clinic expansion carries execution and integration risk and weighs on near-term profit, while share-based compensation and ongoing BC Partners stock sales create dilution and overhang. Finally, the stock often trades at a premium that already bakes in continued margin gains, so disappointing customer growth or margin progress can pressure the shares.
How is CHWY valued? (as of FY2025 results (year ended February 1, 2026) and Q1 FY2026 (ended May 3, 2026))
- FY2025 net sales: About $12.60 billion, up 6.2% (roughly 8.3% on a 52-week basis)
- FY2025 net income: About $222.8 million
- FY2025 adjusted EBITDA: About $719 million, up roughly 26%
- FY2025 free cash flow: Record of about $562 million
- Active customers / Autoship: Around 21.3 million active customers; Autoship roughly 83% of net sales
- Q1 FY2026 quarter: Net sales about $3.36 billion (+7.7%), net income $94.8 million, diluted EPS $0.23, gross margin 30.1%
Chewy is best read as a profitable but low-margin retailer that is trying to mix in higher-margin revenue, so watch the trend in gross margin and adjusted EBITDA margin more than headline sales growth. Because product sales dominate, net margins are thin (low single digits), and free cash flow is often a cleaner gauge of health than GAAP net income, which can be swung by share-based compensation and tax items. Active-customer growth and net sales per active customer show whether the base is expanding or just spending more. Since Chewy pays no dividend and reinvests in pharmacy, ads, and vet care while buying back stock, the valuation hinges on whether those higher-margin businesses scale fast enough to justify a growth multiple.
How do you decide if CHWY is a buy?
Rather than asking whether CHWY is a buy in the abstract, it tends to help to answer four questions:
- Thesis: do you believe the case above, and is it still true today?
- Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
- Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
- Overlap: check whether you already hold CHWY indirectly through an index or sector ETF before adding more.
For the full picture, see the CHWY stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about CHWY against your real portfolio and see your actual exposure before deciding.
The bottom line on CHWY
The bottom line: Chewy's story right now is Autoship makes the revenue sticky, with fy2025 net sales at About $12.60 billion, up 6.2% (roughly 8.3% on a 52-week basis). If you believe that narrative continues, the call is about sizing CHWY sensibly and checking overlap with what you own; if you doubt it (the risk: chewy operates in a structurally low-margin retail business, so even with mix improvements its net margins sit in the low single digits and small cost or pricing shifts matter a lot.), it is not for you. Decide from the thesis, not the ticker. Walnut is not an investment adviser.
Build a basket around CHWY with Walnut
Use Chewy as one constituent in a thematic basket Walnut's AI helps you assemble. Describe a thesis you believe in, the AI proposes the holdings and weights, and you approve before any broker order.
FAQ
Is CHWY a good stock to buy right now?
+
The case for Chewy right now is Autoship makes the revenue sticky, with fy2025 net sales at About $12.60 billion, up 6.2% (roughly 8.3% on a 52-week basis). If you believe that thesis holds, CHWY is a way to own it and the real questions are sizing and overlap, not timing; the main risk to that view is chewy operates in a structurally low-margin retail business, so even with mix improvements its net margins sit in the low single digits and small cost or pricing shifts matter a lot. So it comes down to whether you believe the thesis. Walnut is not an investment adviser and this is not a recommendation.
What does Chewy do?
+
The largest US online pet retailer, built around its Autoship subscription and expanding into higher-margin pharmacy, advertising, and vet-care businesses.
What are the main risks of CHWY?
+
Chewy operates in a structurally low-margin retail business, so even with mix improvements its net margins sit in the low single digits and small cost or pricing shifts matter a lot. Growth has slowed as the US pet market matures, with net sales up only about 6% in fiscal 2025 and active-customer growth modest after a long stretch of flat-to-declining counts following the pandemic pet boom. Competition is intense and well-capitalized: Amazon, Walmart, big-box pet chains like PetSmart and Petco, and local veterinarians all compete for the same wallet. The vet-clinic expansion carries execution and integration risk and weighs on near-term profit, while share-based compensation and ongoing BC Partners stock sales create dilution and overhang. Finally, the stock often trades at a premium that already bakes in continued margin gains, so disappointing customer growth or margin progress can pressure the shares.
What does Chewy do?
+
Chewy is the largest online retailer of pet products in the US. It sells pet food, treats, supplies, and prescription medications, mostly through its Autoship auto-replenishment subscription, and is expanding into pet healthcare with Chewy Pharmacy, a retail-media advertising network, and a growing chain of Chewy Vet Care clinics.
Does CHWY pay a dividend?
+
No. Chewy does not pay a dividend. It returns capital to shareholders through share repurchases instead, deploying roughly $200 million on buybacks in the first quarter of fiscal 2026, partly to offset dilution from share-based compensation and stock sold by its longtime backer BC Partners.
What is Autoship and why does it matter?
+
Autoship is Chewy's subscription that automatically reships food and supplies on a set schedule. It accounts for roughly 83% of net sales, which gives Chewy unusually predictable, recurring revenue for a retailer because pet food and medications are repeat, non-discretionary purchases.
How is Chewy growing beyond selling pet food?
+
Chewy is layering higher-margin businesses onto product sales. Chewy Ads, its retail-media network, has roughly doubled its advertisers since launch and is a main driver of gross-margin gains, while Chewy Pharmacy and an expanding vet-clinic network (lifted toward 47 sites by the 2026 Modern Animal acquisition, targeting around 60) aim to capture more of the large pet-healthcare market.
Walnut is informational and is not an investment adviser. This page is educational and not a recommendation to buy or sell CHWY; figures are approximate and dated, and your own situation, time horizon, and risk tolerance should drive any decision. Verify current data before investing.